Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-8-methyl-5,7-bis(3-methyl-2-buten-1-yl)-1-(2-methyl-1-oxopropyl)-8-(4-methyl-3-penten-1-yl)-,(1R,5R,7S,8R)- (122890-66-8)

Identification
Name:	Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-8-methyl-5,7-bis(3-methyl-2-buten-1-yl)-1-(2-methyl-1-oxopropyl)-8-(4-methyl-3-penten-1-yl)-,(1R,5R,7S,8R)-
Synonyms:	Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-8-methyl-5,7-bis(3-methyl-2-butenyl)-1-(2-methyl-1-oxopropyl)-8-(4-methyl-3-pentenyl)-,(1R,5R,7S,8R)- (9CI); Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-8-methyl-5,7-bis(3-methyl-2-butenyl)-1-(2-methyl-1-oxopropyl)-8-(4-methyl-3-pentenyl)-,[1R-(7-exo,8-endo)]-; Hyperevolutin A
CAS:	122890-66-8
Molecular Formula:	C30H44 O4
Molecular Structure:
Properties
Safety Data

Other Product

Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8-methyl-1,5,7-tris(3-methyl-2-buten-1-yl)-8-(4-methyl-3-penten-1-yl)-,(1R,5R,7R,8S)-rel-(+)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-methoxy-6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxobutyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-5,7-bis[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-4-hydroxy-8,8-dimethyl-1-(3-methyl-2-buten-1-yl)-,(1R,5R,7S)-rel-(-)-
Bicyclo[3.3.1]nonane-2,4,9-trione,6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-3-[[(4aS,5R,8R,8aS)-3,4,4a,5,6,7,8,8a-octahydro-5-hydroperoxy-5-methyl-8-(1-methylethyl)-2-naphthalenyl]methyl]-,(1R,3R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methyl-2-buten-1-yl)-5-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-,(1R,5R,7R)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methyl-2-buten-1-yl)-5-[(2S)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-,(1R,5R,7R)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methyl-2-buten-1-yl)-5-[(2S)-5-methyl-2-(1-methylethyl)-4-hexen-1-yl]-,(1R,5R,7R)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methylbutyl)-5-(2-methyl-1-oxopropyl)-6-(4-methylpentyl)-, (1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methyl-2-buten-1-yl)-5-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-,(1S,5S,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-butenyl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-pentenyl)-, (1R,5S,6R,7S)-, compd. withN-cyclohexylcyclohexanamine (1:1)
2,4(1H,3H)-Pyrimidinedione,5-methyl-1-[(1R,5R,8R)-3-oxo-2-azabicyclo[3.3.1]non-8-yl]-
Bicyclo[3.3.1]non-3-ene-2,9-dione,5-(3,4- dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-3,- 7-bis(3-methyl-2-butenyl)-1-[(2R)-5- methyl-2-(1-methylethenyl)-4-hexenyl]-,(1R,5S,7S)-rel-(-)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-butenyl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-pentenyl)-, sodium salt, (1R,5S,6R,7S)-
Bicyclo[4.1.0]hept-2-ene-3-methanol,7-methyl-7-(4-methyl-3-penten-1-yl)-, (1R,6S,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8-methyl-1,7-bis(3-methyl-2-butenyl)-5-[5-methyl-2-(1-methylethenyl)-4-hexenyl]-8-(4-methyl-3-pentenyl)-(9CI)
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8-methyl-1,7-bis(3-methyl-2-butenyl)-5-[5-methyl-2-(1-methylethenyl)-5-hexenyl]-8-(4-methyl-3-pentenyl)-(9CI)
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-3-(4-hydroxy-3-methoxybenzoyl)-8,8-dimethyl-1,7-bis(3-methyl-2-butenyl)-5-[(2S)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-,(1R,5R,7R)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,5-benzoyl-1-[(4,4-dimethyl-2-methylenecyclohexyl)methyl]-4-hydroxy-6,6-dimethyl-3,7-bis(3-methyl-2-butenyl)-, (1R,5S)-rel-